Cancer stem cell molecular markers verified in vivo


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

This systematic review was aimed at identification of cancer stem cells (CSC) molecular markers, which was validated in experiments on transplantation of tumor subpopulations with different phenotypes to immunodeficient animals. After careful examination of available papers, we selected 97 reports, fully consistent with the objectives of the study. The results of their analysis show that markers commonly used for CSC isolation include: CD133, СD44, ALDH, CD34, CD24, and EpCAM. The review also contains description of molecular features of some CSC markers; it also considers modern approaches to cancer treatment by targeting this population and evaluates perspectives of further development of the CSC theory.

About the authors

Y. S. Kim

Institute of Biomedical Chemistry

Author for correspondence.
Email: yankimhcc@gmail.com
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

A. M. Kaidina

Institute of Biomedical Chemistry

Email: yankimhcc@gmail.com
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

J.-H. Chiang

National Cheng Kung University

Email: yankimhcc@gmail.com
Taiwan, Province of China, Tainan City

K. N. Yarygin

Institute of Biomedical Chemistry

Email: yankimhcc@gmail.com
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

A. Yu. Lupatov

Institute of Biomedical Chemistry

Email: yankimhcc@gmail.com
Russian Federation, ul. Pogodinskaya 10, Moscow, 119121

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Pleiades Publishing, Ltd.